Sound Pharmaceuticals Lands $6,048,261 New Round

  • Feed Type
  • Date
    10/16/2013
  • Company Name
    Sound Pharmaceuticals
  • Mailing Address
    4010 Stone Way N Seattle, WA 98103
  • Company Description
    Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical company in Seattle, WA. Our goal is to develop prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans.
  • Website
    http://www.soundpharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,048,261
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.